Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders' Equity (Unaudited)

v3.22.2
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total stockholders’ equity   $ 8 $ 414,819 $ (58,783)
Balance, beginning of period at Dec. 31, 2020   8 414,819 (58,783)
Fair value of private warrants converted to public warrants     45,515  
Stock-based compensation expense     20,696  
Stock issued under stock compensation plan     2,466  
Issuance of common stock, net of issuance costs   1 (890)  
Exercise of warrants, net of issuance costs     138,202  
Net (loss) income $ (55,486)     (55,486)
Balance, end of period at Jun. 30, 2021 506,548 9 620,808 (114,269)
Total stockholders’ equity   8 435,782 (153,517)
Balance, beginning of period at Mar. 31, 2021   8 435,782 (153,517)
Fair value of private warrants converted to public warrants     31,593  
Costs related to warrants     0  
Stock-based compensation expense     14,031  
Stock issued under stock compensation plan     1,275  
Issuance of common stock, net of issuance costs   1 (75)  
Exercise of warrants, net of issuance costs     138,202  
Net (loss) income 39,248     39,248
Balance, end of period at Jun. 30, 2021 506,548 9 620,808 (114,269)
Total stockholders’ equity 506,548 9 620,808 (114,269)
Total stockholders’ equity 500,265 10 619,145 (118,890)
Balance, beginning of period at Dec. 31, 2021 500,265 10 619,145 (118,890)
Fair value of private warrants converted to public warrants     0  
Costs related to warrants     (55)  
Stock-based compensation expense     27,983  
Stock issued under stock compensation plan     493  
Issuance of common stock, net of issuance costs   0 0  
Exercise of warrants, net of issuance costs     0  
Net (loss) income (56,831)     (56,831)
Balance, end of period at Jun. 30, 2022 471,855 10 647,566 (175,721)
Total stockholders’ equity   10 633,213 (145,276)
Balance, beginning of period at Mar. 31, 2022   10 633,213 (145,276)
Fair value of private warrants converted to public warrants     0  
Costs related to warrants     0  
Stock-based compensation expense     14,233  
Stock issued under stock compensation plan     120  
Issuance of common stock, net of issuance costs   0 0  
Exercise of warrants, net of issuance costs     0  
Net (loss) income (30,445)     (30,445)
Balance, end of period at Jun. 30, 2022 471,855 10 647,566 (175,721)
Total stockholders’ equity $ 471,855 $ 10 $ 647,566 $ (175,721)